共 50 条
- [2] Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study Ophthalmology and Therapy, 2024, 13 : 935 - 954
- [4] PREDICTORS AND IMPORTANCE OF COMPLETE POLYPOIDAL LESION REGRESSION IN THE EVEREST II STUDY Predictors of Polyp Regression in Polypoidal Choroidal Vasculopathy RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (11): : 2091 - 2098
- [8] EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 (05): : 614 - 620
- [10] RANIBIZUMAB WITH OR WITHOUT VERTEPORFIN PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY Predictors of Visual and Anatomical Response in the EVEREST II Study RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (02): : 387 - 392